Delivery Order SPE2DB25D3201-SPE2DB25FNNWF

Award Date 11/13/24
Potential Completion Date 11/14/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,237.68 firm fixed price delivery order is for the supply of 4,566,307,621 tablets of the cardiovascular medication Metoprolol Succinate Extended Release 100 mg. The contract has a completion date of November 4, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to...
This federal contract award, valued at $1,098.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of 4,568,076,308 units of Metoprolol Succinate Extended-Release 100 mg Tablets. The contract has a performance period extending through April 30, 2025 and is priced on a firm-fixed-price basis. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $8,208.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Metoprolol Succinate Extended-Release Tablets, a cardiovascular medication, with a completion date of November 10, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,246.00 firm fixed price delivery order is for the supply of 4559169460 units of Metoprolol Succinate Extended-Release 25 mg tablets. This award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,029.38 firm fixed-price delivery order is for the supply of 4,560,481,760 units of Metoprolol Succinate ER 100 mg tablets. The contract has an ultimate completion date of March 29, 2023 and was awarded on March 28, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, ID SPE2DB20D3103|SPE2DB23FP2F4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $4,195.61 firm fixed-price delivery order is for the supply of 4,561,683,147 units of Metoprolol Succinate Extended-Release 200 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of August 3, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 1,000 units of the medication Metoprolol Succinate Extended-Release 25 mg tablets. The contract has a ceiling value of $1,002.04 and is a firm fixed-price delivery order, meaning the price is set and will not change. It is not designated as a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $843,498.58, is a delivery order awarded as a firm-fixed-price contract to provide a range of pharmaceutical products and medical supplies to support military healthcare programs. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and...
This federal contract award, valued at $89,274.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the provision of a comprehensive range of pharmaceutical products and medical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $129,765.60, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA, which is valued at $999,999,999 and runs through November 2026. The contract is for the provision of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNNWF
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for $1,308.84 to provide Metoprolol Succinate Extended-Release Tablets, a cardiovascular medication, to support military healthcare programs. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for supplying a wide range of pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive experience and capabilities in pharmaceutical distribution to the federal government make it a key vendor for essential medical commodities across various therapeutic areas.

Generated 5/20/25, 1:55 PM